// April 18, 2024
USP’s commitment to ESG considerations for a healthier, more sustainable world
At the U.S.
At the U.S.
Interest in innovative vaccines that use messenger ribonucleic acid (mRNA) and viral vectored tec
Revised on: January 17, 2023
To those in the pharmaceutical industry, USP may be both familiar and a little myster